BioCentury
ARTICLE | Clinical News

Avycaz ceftazidime/avibactam: Phase III data

September 7, 2015 7:00 AM UTC

Avycaz is marketed in the U.S. to treat cUTI and complicated intra-abdominal infections (cIAI). By year end, Allergan plans to submit an sNDA to FDA to include data from RECAPTURE 1 and RECAPTURE 2 in...